TXA administered intravenously, by injection reduces blood loss after knee replacement

Posted by on May 19, 2016 8:12 pm
Categories: health

Administering tranexamic acid (TXA) both intravenously (IV) and injected at the surgical site (intra-articular administration, or IA) reduced blood loss by 37 percent, compared to IV alone, following total knee replacement (TKR).

Leave a Reply

Your email address will not be published. Required fields are marked *